安裝中文字典英文字典查詢工具!
中文字典英文字典工具:
複製到剪貼板
英文字典中文字典相關資料:
Myasthenia Gravis Treatment: 5 Things to Know - Medscape Myasthenia gravis, a rare autoimmune disease, can have devastating consequences Stay current on the latest and emerging MG treatments with these five things to know
Self-Administered Med Shows Promise in Myasthenia Gravis Weekly subcutaneous gefurulimab delivered early is linked to lasting symptom improvement in patients with generalized myasthenia gravis in phase 3 PREVAIL trial
New Hope for Hard-to-Treat Myasthenia Gravis - Medscape New phase 3 data show meaningful improvement in antibody-negative myasthenia gravis, for which treatment options are limited and patients face persistent unmet clinical needs
Key Updates in Myasthenia Gravis From AANEM 2025 - Medscape Myasthenia gravis updates from AANEM 2025 include efficacy data for efgartigimod, telitacicept, and gefurulimab, plus interim results for a CAR T-cell therapy and DNTH10, an active C1S inhibitor
AANEM 2025: Key Highlights in Myasthenia Gravis - Medscape Dr Katherine Ruzhansky recounts how new diagnostic biomarkers and therapies are improving outcomes for patients with myasthenia gravis
Myasthenia Gravis Med Tied to Major Reduction in Steroid Use 18-month data show patients with generalized myasthenia gravis taking efgartigimod were able to reduce glucocorticoids to low levels or discontinue them
Conference MDAngle: AAN 2026 Myasthenia Gravis - Medscape Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis may affect patient care
AANEM 2025: Previewing Innovations in Myasthenia Gravis - Medscape The upcoming 2025 AANEM Annual Meeting promises exciting updates in myasthenia gravis (MG) research, clinical care, and treatment innovation, reflecting significant progress over the past decade
FDA Approves Uplizna for Generalized Myasthenia Gravis - Medscape The B-cell depleting therapy is indicated for adults with generalized myasthenia gravis and anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibodies